199 related articles for article (PubMed ID: 12473647)
1. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.
Abdollahi A; Pisarcik D; Roberts D; Weinstein J; Cairns P; Hamilton TC
J Biol Chem; 2003 Feb; 278(8):6041-9. PubMed ID: 12473647
[TBL] [Abstract][Full Text] [Related]
2. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
3. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
Abdollahi A
J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
[TBL] [Abstract][Full Text] [Related]
4. The mouse Zac1 locus: basis for imprinting and comparison with human ZAC.
Smith RJ; Arnaud P; Konfortova G; Dean WL; Beechey CV; Kelsey G
Gene; 2002 Jun; 292(1-2):101-12. PubMed ID: 12119104
[TBL] [Abstract][Full Text] [Related]
5. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines.
Piras G; El Kharroubi A; Kozlov S; Escalante-Alcalde D; Hernandez L; Copeland NG; Gilbert DJ; Jenkins NA; Stewart CL
Mol Cell Biol; 2000 May; 20(9):3308-15. PubMed ID: 10757814
[TBL] [Abstract][Full Text] [Related]
6. LOT1 (ZAC1/PLAGL1) as member of an imprinted gene network does not harbor Silver-Russell specific variants.
Jäger S; Schönherr N; Spengler S; Ranke MB; Wollmann HA; Binder G; Eggermann T
J Pediatr Endocrinol Metab; 2009 Jun; 22(6):555-9. PubMed ID: 19694203
[TBL] [Abstract][Full Text] [Related]
7. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
Arima T; Yamasaki K; John RM; Kato K; Sakumi K; Nakabeppu Y; Wake N; Kono T
Genomics; 2006 Nov; 88(5):650-8. PubMed ID: 16928428
[TBL] [Abstract][Full Text] [Related]
8. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.
Abdollahi A; Bao R; Hamilton TC
Oncogene; 1999 Nov; 18(47):6477-87. PubMed ID: 10597250
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.
Varrault A; Bilanges B; Mackay DJ; Basyuk E; Ahr B; Fernandez C; Robinson DO; Bockaert J; Journot L
J Biol Chem; 2001 Jun; 276(22):18653-6. PubMed ID: 11297535
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
Kamikihara T; Arima T; Kato K; Matsuda T; Kato H; Douchi T; Nagata Y; Nakao M; Wake N
Int J Cancer; 2005 Jul; 115(5):690-700. PubMed ID: 15751035
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
Valleley EM; Cordery SF; Bonthron DT
Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
[TBL] [Abstract][Full Text] [Related]
12. Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.
Li Z; Ding Y; Zhu Y; Yin M; Le X; Wang L; Yang Y; Zhang Q
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):744-50. PubMed ID: 25091631
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
14. Imprinting at the PLAGL1 domain is contained within a 70-kb CTCF/cohesin-mediated non-allelic chromatin loop.
Iglesias-Platas I; Court F; Camprubi C; Sparago A; Guillaumet-Adkins A; Martin-Trujillo A; Riccio A; Moore GE; Monk D
Nucleic Acids Res; 2013 Feb; 41(4):2171-9. PubMed ID: 23295672
[TBL] [Abstract][Full Text] [Related]
15. Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.
Lemeta S; Jarmalaite S; Pylkkänen L; Böhling T; Husgafvel-Pursiainen K
J Neuropathol Exp Neurol; 2007 Sep; 66(9):860-7. PubMed ID: 17805016
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
[TBL] [Abstract][Full Text] [Related]
17. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
[TBL] [Abstract][Full Text] [Related]
19. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
